Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1371-1380 of 1760 for cancer

Edit search filters
  1. A Study to Establish a Living Breast Organoid Biobank for Translational Research

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Assess Endometrial Cancer Recurrence In Patients After 36 Months

    Rochester, MN

  3. Outcomes Database To ProspectivelY ASSEss The Changing TherapY Landscape In Renal Cell Carcinoma (ODYSSEY RCC)

    Rochester, MN

  4. Role Of Immunity In Efficacy Of Chemotherapy Plus Trastuzumab

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Collecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders

    Rochester, MN

  6. Female Patients And Female Partners Of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (Pap-Op): Prospective Assessment Of HPV Associated Anogenital Pathology

    Rochester, MN

  7. A Study to Evaluate Brain Natriuretic Peptides for the Avoidance of Treatment-Related Heart Failure in Breast Cancer Survivors

    Rochester, MN

  8. Validation Of A Blood Assay For The Detection Of BRAF Mutation Status In Patients With Metastatic Melanoma

    Rochester, MN

  9. A Study To Better Understand How To Predict And Manage Patients Who Are At High Risk For Developing Rheumatic Immune-related Adverse Events While Receiving Treatment For Melanoma

    Rochester, MN

  10. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

.

Mayo Clinic Footer